Literature DB >> 25487496

Analysis of recurrence risks for sacrococcygeal teratoma in children.

Wei Yao1, Kai Li2, Shan Zheng1, Kuiran Dong1, Xianmin Xiao1.   

Abstract

BACKGROUND/
PURPOSE: The purpose of this study was to investigate effects of risk factors on recurrence of sacrococcygeal teratoma (SCT).
METHODS: A retrospective review was conducted of 107 SCTs treated between January 2003 and December 2012 in our center. Risk factors were identified by univariate and multivariate analysis.
RESULTS: Sixteen children had recurrence of SCT a median interval of 16.25months after primary surgery. 15.6% tumors recurrence were Altman type I, 10.5% type II, 10.0% type III, and 31.3% type IV. The recurrence of mature teratoma was observed in 8 patients, immature in 2, malignant in 5. More than half of the recurrences showed a shift towards histological immaturity or malignancy, compared with the primary tumor pathology. Risk factors for recurrence were spillage of tumor parenchyma during operation (P=0.028), incomplete resection (p=0.000), and primary immature (P=0.029) and malignant histology (P=0.026). Size, Altman classification, and age were not risk factors for recurrence. There was a statistically significant difference in OS between patients who developed relapse (64.8%) and those who did not (95.0%) (P=0.0002).
CONCLUSIONS: Tumor recurrence affected the outcome of children with SCT. Risk factors were tumor spillage, immature and malignant histology, or incomplete resection. Regular follow-up after surgery is mandatory to find tumor relapse earlier and to improve the outcome.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Recurrence; Risk factors; Sacrococcygeal teratoma

Mesh:

Year:  2014        PMID: 25487496     DOI: 10.1016/j.jpedsurg.2014.09.036

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

1.  Use of intraoperative lateral pelvic X-ray to localize and ensure coccyx removal during sacrococcygeal teratoma resection.

Authors:  Claire E Graves; Olajire Idowu; John Zovickian; Dachling Pang; Sunghoon Kim
Journal:  Pediatr Surg Int       Date:  2016-11-17       Impact factor: 1.827

2.  Sacrococcygeal teratoma: late recurrence warrants long-term surveillance.

Authors:  Benjamin E Padilla; Lan Vu; Hanmin Lee; Tippi MacKenzie; Barbara Bratton; Maura O'Day; Sarkis Derderian
Journal:  Pediatr Surg Int       Date:  2017-09-11       Impact factor: 1.827

Review 3.  Management of fetal teratomas.

Authors:  Jose L Peiró; Lourenço Sbragia; Federico Scorletti; Foong Y Lim; Aimen Shaaban
Journal:  Pediatr Surg Int       Date:  2016-04-25       Impact factor: 1.827

4.  Sacrococcygeal Teratoma : A Tumor at the Center of Embryogenesis.

Authors:  Ji Hoon Phi
Journal:  J Korean Neurosurg Soc       Date:  2021-04-29

5.  Type IV Sacrococcygeal Teratoma Displacing the Urinary Bladder: Unique Magnetic Resonance Imaging.

Authors:  Sahar Eftekharzadeh; Sorena Keihani; Mehdi Fareghi; Alireza Alamsahebpour; Abdol-Mohammad Kajbafzadeh
Journal:  Case Rep Urol       Date:  2016-06-20

6.  Analysis of Recurrent Sacrococcygeal Teratoma in Children: Clinical Features, Relapse Risks, and Anorectal Functional Sequelae.

Authors:  Yi Wang; Yeming Wu; Lifeng Wang; Xiaojun Yuan; Mawei Jiang; Yuhua Li
Journal:  Med Sci Monit       Date:  2017-01-02

7.  Surgical treatment of a type IV cystic sacrococcygeal teratoma with intraspinal extension utilizing a posterior-anterior-posterior approach: a case report.

Authors:  Aaron Wessell; David S Hersh; Cheng-Ying Ho; Kimberly M Lumpkins; Mari L A Groves
Journal:  Childs Nerv Syst       Date:  2018-01-24       Impact factor: 1.475

8.  Malignant sacrococcygeal germ cell tumors in children in Taiwan: A retrospective single-center case series.

Authors:  Shih-Hsiang Chen; Chia-Jui Du; Jin-Yao Lai; Tsung-Yen Chang; Chao-Ping Yang; Iou-Jih Hung; Tang-Her Jaing; Yung-Ching Ming; Chuen Hsueh
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.